• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质结晶:突破X射线晶体学的瓶颈

Protein crystallization: Eluding the bottleneck of X-ray crystallography.

作者信息

Holcomb Joshua, Spellmon Nicholas, Zhang Yingxue, Doughan Maysaa, Li Chunying, Yang Zhe

机构信息

Department of Microbiology, Immunology, and Biochemistry, Wayne State University School of Medicine, Detroit, MI, USA.

Center for Molecular and Translational Medicine, Georgia State University, Atlanta, GA, USA.

出版信息

AIMS Biophys. 2017;4(4):557-575. doi: 10.3934/biophy.2017.4.557. Epub 2017 Sep 26.

DOI:10.3934/biophy.2017.4.557
PMID:29051919
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5645037/
Abstract

To date, X-ray crystallography remains the gold standard for the determination of macromolecular structure and protein substrate interactions. However, the unpredictability of obtaining a protein crystal remains the limiting factor and continues to be the bottleneck in determining protein structures. A vast amount of research has been conducted in order to circumvent this issue with limited success. No single method has proven to guarantee the crystallization of all proteins. However, techniques using antibody fragments, lipids, carrier proteins, and even mutagenesis of crystal contacts have been implemented to increase the odds of obtaining a crystal with adequate diffraction. In addition, we review a new technique using the scaffolding ability of PDZ domains to facilitate nucleation and crystal lattice formation. Although in its infancy, such technology may be a valuable asset and another method in the crystallography toolbox to further the chances of crystallizing problematic proteins.

摘要

迄今为止,X射线晶体学仍然是确定大分子结构和蛋白质底物相互作用的金标准。然而,获得蛋白质晶体的不可预测性仍然是限制因素,并且仍然是确定蛋白质结构的瓶颈。为了规避这个问题,已经进行了大量研究,但取得的成功有限。没有一种单一方法被证明能保证所有蛋白质都结晶。然而,已经采用了使用抗体片段、脂质、载体蛋白甚至晶体接触诱变等技术来增加获得具有足够衍射能力晶体的几率。此外,我们还综述了一种利用PDZ结构域的支架能力来促进成核和晶格形成的新技术。尽管这项技术尚处于起步阶段,但它可能是一项有价值的资产,也是晶体学工具箱中的另一种方法,可进一步提高使有问题的蛋白质结晶的机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d331/5645037/6ec7ff184cbf/nihms909579f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d331/5645037/9e0d8f6d79ff/nihms909579f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d331/5645037/6ec7ff184cbf/nihms909579f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d331/5645037/9e0d8f6d79ff/nihms909579f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d331/5645037/6ec7ff184cbf/nihms909579f2.jpg

相似文献

1
Protein crystallization: Eluding the bottleneck of X-ray crystallography.蛋白质结晶:突破X射线晶体学的瓶颈
AIMS Biophys. 2017;4(4):557-575. doi: 10.3934/biophy.2017.4.557. Epub 2017 Sep 26.
2
Determination of soluble and membrane protein structures by X-ray crystallography.通过X射线晶体学确定可溶性和膜蛋白结构。
Methods Mol Biol. 2013;955:475-93. doi: 10.1007/978-1-62703-176-9_25.
3
An attempt to increase the efficiency of protein crystal screening: a simplified screen and experiments.提高蛋白质晶体筛选效率的尝试:一种简化的筛选方法及实验
Acta Crystallogr D Biol Crystallogr. 2005 Jun;61(Pt 6):776-9. doi: 10.1107/S0907444905014708. Epub 2005 May 26.
4
A comprehensive review of the lipid cubic phase or in meso method for crystallizing membrane and soluble proteins and complexes.关于脂质立方相或介观法结晶膜蛋白、可溶性蛋白及复合物的全面综述。
Acta Crystallogr F Struct Biol Commun. 2015 Jan 1;71(Pt 1):3-18. doi: 10.1107/S2053230X14026843.
5
An All-in-one Sample Holder for Macromolecular X-ray Crystallography with Minimal Background Scattering.一种用于大分子X射线晶体学的一体化样品架,背景散射极小。
J Vis Exp. 2019 Jul 6(149). doi: 10.3791/59722.
6
Entropy and surface engineering in protein crystallization.蛋白质结晶中的熵与表面工程
Acta Crystallogr D Biol Crystallogr. 2006 Jan;62(Pt 1):116-24. doi: 10.1107/S0907444905035237. Epub 2005 Dec 14.
7
Increasing protein crystallization screening success with heterogeneous nucleating agents.使用异质成核剂提高蛋白质结晶筛选成功率。
Methods Mol Biol. 2008;426:403-9. doi: 10.1007/978-1-60327-058-8_26.
8
High-Throughput Screening to Obtain Crystal Hits for Protein Crystallography.高通量筛选获得蛋白质晶体学的晶体命中。
J Vis Exp. 2023 Mar 10(193). doi: 10.3791/65211.
9
Effects of protein engineering and rational mutagenesis on crystal lattice of single chain antibody fragments.蛋白质工程和理性诱变对单链抗体片段晶格的影响。
Proteins. 2014 Sep;82(9):1884-95. doi: 10.1002/prot.24542. Epub 2014 Mar 24.
10
Determining the Crystal Structure of TRPV6确定瞬时受体电位香草酸亚型6(TRPV6)的晶体结构

引用本文的文献

1
Sensing Protein Structural Transitions with Microfluidic Modulation Infrared Spectroscopy.利用微流控调制红外光谱传感蛋白质结构转变
Biosensors (Basel). 2025 Jun 13;15(6):382. doi: 10.3390/bios15060382.
2
Structural Virology: The Key Determinants in Development of Antiviral Therapeutics.结构病毒学:抗病毒治疗药物研发中的关键决定因素
Viruses. 2025 Mar 14;17(3):417. doi: 10.3390/v17030417.
3
Heterogeneous Nucleation in Protein Crystallization.蛋白质结晶中的异质成核

本文引用的文献

1
Nanodiamonds as Nucleating Agents for Protein Crystallization.纳米金刚石作为蛋白质结晶的成核剂。
Langmuir. 2017 Jul 5;33(26):6521-6527. doi: 10.1021/acs.langmuir.7b00578. Epub 2017 Jun 21.
2
Protein crystal nucleation in pores.蛋白晶体在孔中的成核。
Sci Rep. 2017 Jan 16;7:35821. doi: 10.1038/srep35821.
3
Nanobodies to Study G Protein-Coupled Receptor Structure and Function.用于研究G蛋白偶联受体结构与功能的纳米抗体
Biomimetics (Basel). 2023 Feb 6;8(1):68. doi: 10.3390/biomimetics8010068.
4
X-ray Crystallography: Seeding Technique with Cytochrome P450 Reductase.X射线晶体学:细胞色素P450还原酶的接种技术
Bio Protoc. 2022 Nov 5;12(21). doi: 10.21769/BioProtoc.4546.
5
Advances in antibody discovery from human BCR repertoires.从人类 B 细胞受体库中发现抗体的进展。
Front Bioinform. 2022 Oct 20;2:1044975. doi: 10.3389/fbinf.2022.1044975. eCollection 2022.
6
Non-covalent Fc-Fab interactions significantly alter internal dynamics of an IgG1 antibody.非共价 Fc-Fab 相互作用显著改变 IgG1 抗体的内部动力学。
Sci Rep. 2022 Jun 4;12(1):9321. doi: 10.1038/s41598-022-13370-3.
7
Studying the Structures of Relaxed and Fuzzy Interactions: The Diverse World of S100 Complexes.研究松弛和模糊相互作用的结构:S100复合物的多样世界。
Front Mol Biosci. 2021 Oct 11;8:749052. doi: 10.3389/fmolb.2021.749052. eCollection 2021.
8
Nanobody-aided crystallization of the transcription regulator PaaR2 from Escherichia coli O157:H7.纳米抗体辅助结晶大肠杆菌 O157:H7 转录调控因子 PaaR2。
Acta Crystallogr F Struct Biol Commun. 2021 Oct 1;77(Pt 10):374-384. doi: 10.1107/S2053230X21009006. Epub 2021 Sep 21.
9
Computational Approaches: An Underutilized Tool in the Quest to Elucidate Radical SAM Dynamics.计算方法:阐明激进 SAM 动力学的未充分利用工具。
Molecules. 2021 Apr 29;26(9):2590. doi: 10.3390/molecules26092590.
10
Co-crystallization with diabodies: A case study for the introduction of synthetic symmetry.与双抗体共结晶:引入合成对称的案例研究。
Structure. 2021 Jun 3;29(6):598-605.e3. doi: 10.1016/j.str.2021.02.001. Epub 2021 Feb 25.
Annu Rev Pharmacol Toxicol. 2017 Jan 6;57:19-37. doi: 10.1146/annurev-pharmtox-010716-104710. Epub 2016 Dec 7.
4
Protein Crystallization in an Actuated Microfluidic Nanowell Device.在一种驱动式微流控纳米阱装置中的蛋白质结晶
Cryst Growth Des. 2016;16(4):2074-2082. doi: 10.1021/acs.cgd.5b01748. Epub 2016 Feb 25.
5
Quasi-Racemic X-ray Structures of K27-Linked Ubiquitin Chains Prepared by Total Chemical Synthesis.通过全化学合成制备的 K27 连接的泛素链的准外消旋 X 射线结构。
J Am Chem Soc. 2016 Jun 15;138(23):7429-35. doi: 10.1021/jacs.6b04031. Epub 2016 Jun 6.
6
Current trends in protein crystallization.蛋白质结晶的当前趋势。
Arch Biochem Biophys. 2016 Jul 15;602:3-11. doi: 10.1016/j.abb.2015.12.010. Epub 2015 Dec 31.
7
Crystal structures of MBP fusion proteins.MBP融合蛋白的晶体结构。
Protein Sci. 2016 Mar;25(3):559-71. doi: 10.1002/pro.2863. Epub 2016 Jan 9.
8
A comprehensive review of the lipid cubic phase or in meso method for crystallizing membrane and soluble proteins and complexes.关于脂质立方相或介观法结晶膜蛋白、可溶性蛋白及复合物的全面综述。
Acta Crystallogr F Struct Biol Commun. 2015 Jan 1;71(Pt 1):3-18. doi: 10.1107/S2053230X14026843.
9
PDZ Structure and Implication in Selective Drug Design against Cystic Fibrosis.PDZ结构及其在针对囊性纤维化的选择性药物设计中的意义。
Curr Drug Targets. 2015;16(9):945-50. doi: 10.2174/1389450116666141219120125.
10
Crystal structure of the NHERF1 PDZ2 domain in complex with the chemokine receptor CXCR2 reveals probable modes of PDZ2 dimerization.NHERF1 PDZ2 结构域与趋化因子受体 CXCR2 复合物的晶体结构揭示了 PDZ2 二聚体可能的模式。
Biochem Biophys Res Commun. 2014 May 30;448(2):169-74. doi: 10.1016/j.bbrc.2014.04.085. Epub 2014 Apr 24.